Delivery Order SPE2DB20D3111-SPE2DB25FA8PD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a $4,416.87 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025, with a completion date of July 21, 2025. This competitively awarded, non-set-aside contract represents a routine pharmaceutical delivery under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion master contract valued through December 2026. The place of...
- The Defense Logistics Agency awarded a $1,345.87 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for completion by July 21, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,753.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,148.90 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract, which is not set-aside and uses firm fixed pricing, is scheduled for completion by July 21, 2025, with performance at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement under a larger federal contract vehicle supporting military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 3 mg/0.5 ml pens. The $11,704.32 contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and this delivery order is issued under an indefinite delivery contract (IDC) awarded solely to the company by DLA, with a potential value of up to...
- The Defense Logistics Agency awarded a $4,013.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. The contract, which is classified as a child contract with an ultimate completion date of July 21, 2025, was competitively awarded with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a contract ceiling value of $3,903.90. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The order is scheduled for ultimate completion by July 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,044.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL quantity). The contract, which is not set-aside, is scheduled for completion by June 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA8PDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens valued at $1,417.72 on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply mission for the Defense Logistics Agency's Medical Supply Chain, which serves military healthcare systems and other federal medical procurement needs. Trulicity, a diabetes management medication, represents one of many specialty pharmaceuticals and brand-name drugs the contractor supplies under its DLA prime vendor agreement. AmerisourceBergen's contract portfolio with the Defense Logistics Agency demonstrates the company's capability to fulfill federal medical supply requirements through competitive procurement processes, with delivery orders ranging across multiple therapeutic domains including endocrinology, neurology, pain management, and immunology products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/18/25 |